MicroRNAs and other non-coding RNAs as targets for anticancer drug development (original) (raw)

• Mattick, J. S. The genetic signatures of noncoding RNAs. PLoS Genet. 5, e1000459 (2009).
  PubMed PubMed Central Google Scholar
• Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215–233 (2009).
  CAS PubMed PubMed Central Google Scholar
• Calin, G. A. et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA 99, 15524–15529 (2002).
  CAS PubMed PubMed Central Google Scholar
• Mendell, J. T. & Olson, E. N. MicroRNAs in stress signaling and human disease. Cell 148, 1172–1187 (2012).
  CAS PubMed PubMed Central Google Scholar
• Esquela-Kerscher, A. & Slack, F. J. Oncomirs — microRNAs with a role in cancer. Nature Rev. Cancer 6, 259–269 (2006).
  CAS Google Scholar
• Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature 435, 834–838 (2005).
  CAS PubMed Google Scholar
• Volinia, S. et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl Acad. Sci. USA 103, 2257–2261 (2006).
  CAS PubMed PubMed Central Google Scholar
• Esteller, M. Non-coding RNAs in human disease. Nature Rev. Genet. 12, 861–874 (2011).
  CAS PubMed Google Scholar
• Calin, G. A. & Croce, C. M. MicroRNA signatures in human cancers. Nature Rev. Cancer 6, 857–866 (2006).
  CAS Google Scholar
• Ambros, V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 113, 673–676 (2003).
  CAS PubMed Google Scholar
• Croce, C. M. Causes and consequences of microRNA dysregulation in cancer. Nature Rev. Genet. 10, 704–714 (2009).
  CAS PubMed Google Scholar
• Spizzo, R., Almeida, M. I., Colombatti, A. & Calin, G. A. Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene 31, 4577–4587 (2012).
  CAS PubMed PubMed Central Google Scholar
• Pennisi, E. Genomics. ENCODE project writes eulogy for junk DNA. Science 337, 1159–1161 (2012).
  CAS PubMed Google Scholar
• Dunham, I. et al. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74 (2012).
  CAS Google Scholar
• Djebali, S. et al. Landscape of transcription in human cells. Nature 489, 101–108 (2012).
  CAS PubMed PubMed Central Google Scholar
• Fabian, M. R., Sonenberg, N. & Filipowicz, W. Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 79, 351–379 (2010).
  CAS PubMed Google Scholar
• Garzon, R., Marcucci, G. & Croce, C. M. Targeting microRNAs in cancer: rationale, strategies and challenges. Nature Rev. Drug Discov. 9, 775–789 (2010).
  CAS Google Scholar
• Thorsen, S. B., Obad, S., Jensen, N. F., Stenvang, J. & Kauppinen, S. The therapeutic potential of microRNAs in cancer. Cancer J. 18, 275–284 (2012).
  CAS PubMed Google Scholar
• van Kouwenhove, M., Kedde, M. & Agami, R. MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nature Rev. Cancer 11, 644–656 (2011).
  CAS Google Scholar
• van Rooij, E. & Olson, E. N. MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nature Rev. Drug Discov. 11, 860–872 (2012).
  CAS Google Scholar
• Wahlestedt, C. Targeting long non-coding RNA to therapeutically upregulate gene expression. Nature Rev. Drug Discov. 12, 433–446 (2013).
  CAS Google Scholar
• Tay, Y., Zhang, J., Thomson, A. M., Lim, B. & Rigoutsos, I. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455, 1124–1128 (2008).
  CAS PubMed Google Scholar
• Lytle, J. R., Yario, T. A. & Steitz, J. A. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR. Proc. Natl Acad. Sci. USA 104, 9667–9672 (2007).
  CAS PubMed PubMed Central Google Scholar
• Vasudevan, S., Tong, Y. & Steitz, J. A. Switching from repression to activation: microRNAs can up-regulate translation. Science 318, 1931–1934 (2007).
  CAS PubMed Google Scholar
• Eiring, A. M. et al. miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell 140, 652–665 (2010).
  CAS PubMed PubMed Central Google Scholar
• Orom, U. A., Nielsen, F. C. & Lund, A. H. MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and enhances their translation. Mol. Cell 30, 460–471 (2008).
  PubMed Google Scholar
• Fabbri, M. et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc. Natl Acad. Sci. USA 109, E2110–E2116 (2012).
  CAS PubMed PubMed Central Google Scholar
• Mitchell, P. S. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl Acad. Sci. USA 105, 10513–10518 (2008).
  CAS PubMed PubMed Central Google Scholar
• Arroyo, J. D. et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl Acad. Sci. USA 108, 5003–5008 (2011).
  CAS PubMed PubMed Central Google Scholar
• Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biol. 9, 654–659 (2007).
  CAS PubMed Google Scholar
• Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R. D. & Remaley, A. T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nature Cell Biol. 13, 423–433 (2011).
  CAS PubMed Google Scholar
• Pigati, L. et al. Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS ONE 5, e13515 (2010).
  PubMed PubMed Central Google Scholar
• Cortez, M. A. et al. MicroRNAs in body fluids — the mix of hormones and biomarkers. Nature Rev. Clin. Oncol. 8, 467–477 (2011).
  CAS Google Scholar
• Kasinski, A. L. & Slack, F. J. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nature Rev. Cancer 11, 849–864 (2011).
  CAS Google Scholar
• Spizzo, R., Nicoloso, M. S., Croce, C. M. & Calin, G. A. SnapShot: microRNAs in cancer. Cell 137, 586–586e1 (2009).
  CAS PubMed Google Scholar
• Volinia, S. et al. Reprogramming of miRNA networks in cancer and leukemia. Genome Res. 20, 589–599 (2010).
  CAS PubMed PubMed Central Google Scholar
• Medina, P. P., Nolde, M. & Slack, F. J. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467, 86–90 (2010).
  CAS PubMed Google Scholar
• Hatley, M. E. et al. Modulation of K-Ras-dependent lung tumorigenesis by microRNA-21. Cancer Cell 18, 282–293 (2010).
  CAS PubMed PubMed Central Google Scholar
• Frankel, L. B. et al. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem. 283, 1026–1033 (2008).
  CAS PubMed Google Scholar
• He, L. et al. A microRNA polycistron as a potential human oncogene. Nature 435, 828–833 (2005).
  CAS PubMed PubMed Central Google Scholar
• Mu, P. et al. Genetic dissection of the miR-17∼92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev. 23, 2806–2811 (2009).
  CAS PubMed PubMed Central Google Scholar
• Costinean, S. et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic mice. Proc. Natl Acad. Sci. USA 103, 7024–7029 (2006).
  CAS PubMed PubMed Central Google Scholar
• Nicoloso, M. S., Spizzo, R., Shimizu, M., Rossi, S. & Calin, G. A. MicroRNAs — the micro steering wheel of tumour metastases. Nature Rev. Cancer 9, 293–302 (2009).
  CAS Google Scholar
• Pencheva, N. & Tavazoie, S. F. Control of metastatic progression by microRNA regulatory networks. Nature Cell Biol. 15, 546–554 (2013).
  CAS PubMed Google Scholar
• Png, K. J., Halberg, N., Yoshida, M. & Tavazoie, S. F. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature 481, 190–194 (2012).
  CAS Google Scholar
• Song, S. J. et al. MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling. Cell 154, 311–324 (2013).
  CAS PubMed PubMed Central Google Scholar
• Pineau, P. et al. miR-221 overexpression contributes to liver tumorigenesis. Proc. Natl Acad. Sci. USA 107, 264–269 (2010).
  CAS PubMed Google Scholar
• Felli, N. et al. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc. Natl Acad. Sci. USA 102, 18081–18086 (2005).
  CAS PubMed PubMed Central Google Scholar
• Fabbri, M. et al. Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA 305, 59–67 (2011).
  CAS PubMed PubMed Central Google Scholar
• Mavrakis, K. J. et al. A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL). Nature Genet. 43, 673–678 (2011).
  CAS PubMed Google Scholar
• O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V. & Mendell, J. T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435, 839–843 (2005).
  CAS PubMed Google Scholar
• Uhlmann, S. et al. Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer. Mol. Syst. Biol. 8, 570 (2012).
  PubMed PubMed Central Google Scholar
• Wheeler, D. L., Dunn, E. F. & Harari, P. M. Understanding resistance to EGFR inhibitors — impact on future treatment strategies. Nature Rev. Clin. Oncol. 7, 493–507 (2010).
  CAS Google Scholar
• Calin, G. A. et al. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc. Natl Acad. Sci. USA 105, 5166–5171 (2008).
  CAS PubMed PubMed Central Google Scholar
• Calin, G. A. et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med. 353, 1793–1801 (2005).
  CAS PubMed Google Scholar
• Almeida, M. I. et al. Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells. Gastroenterology 142, 886–896e9 (2012).
  CAS PubMed Google Scholar
• Girardot, M. et al. miR-28 is a thrombopoietin receptor targeting microRNA detected in a fraction of myeloproliferative neoplasm patient platelets. Blood 116, 437–445 (2010).
  CAS PubMed Google Scholar
• Jiang, L. et al. Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells. BMC Cancer 10, 318 (2010).
  PubMed PubMed Central Google Scholar
• Galm, O., Herman, J. G. & Baylin, S. B. The fundamental role of epigenetics in hematopoietic malignancies. Blood Rev. 20, 1–13 (2006).
  CAS PubMed Google Scholar
• Lujambio, A. et al. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res. 67, 1424–1429 (2007).
  CAS PubMed Google Scholar
• Bandres, E. et al. Epigenetic regulation of microRNA expression in colorectal cancer. Int. J. Cancer 125, 2737–2743 (2009).
  CAS PubMed Google Scholar
• Saito, Y. & Jones, P. A. Epigenetic activation of tumor suppressor microRNAs in human cancer cells. Cell Cycle 5, 2220–2222 (2006).
  CAS PubMed Google Scholar
• Melo, S. et al. Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proc. Natl Acad. Sci. USA 108, 4394–4399 (2011).
  CAS PubMed PubMed Central Google Scholar
• Bader, A. G., Brown, D., Stoudemire, J. & Lammers, P. Developing therapeutic microRNAs for cancer. Gene Ther. 18, 1121–1126 (2011).
  CAS PubMed PubMed Central Google Scholar
• Tivnan, A. et al. Inhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD2 coated nanoparticles. PLoS ONE 7, e38129 (2012).
  CAS PubMed PubMed Central Google Scholar
• Trang, P. et al. Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. Mol. Ther. 19, 1116–1122 (2011).
  CAS PubMed PubMed Central Google Scholar
• Tazawa, H., Tsuchiya, N., Izumiya, M. & Nakagama, H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl Acad. Sci. USA 104, 15472–15477 (2007).
  CAS PubMed PubMed Central Google Scholar
• Ji, J. et al. MicroRNA expression, survival, and response to interferon in liver cancer. N. Engl. J. Med. 361, 1437–1447 (2009).
  CAS PubMed PubMed Central Google Scholar
• Kota, J. et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137, 1005–1017 (2009).
  CAS PubMed PubMed Central Google Scholar
• Chen, L. et al. Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways. Mol. Ther. 19, 1521–1528 (2011).
  CAS PubMed PubMed Central Google Scholar
• Bader, A. G. miR-34 — a microRNA replacement therapy is headed to the clinic. Front. Genet. 3, 120 (2012).
  CAS PubMed PubMed Central Google Scholar
• Lennox, K. A. & Behlke, M. A. Chemical modification and design of anti-miRNA oligonucleotides. Gene Ther. 18, 1111–1120 (2011).
  CAS PubMed Google Scholar
• Swarbrick, A. et al. miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma. Nature Med. 16, 1134–1140 (2010).
  CAS PubMed Google Scholar
• Janssen, H. L. et al. Treatment of HCV infection by targeting microRNA. N. Engl. J. Med. 368, 1685–1694 (2013).
  CAS PubMed Google Scholar
• Lieberman, J. & Sarnow, P. Micromanaging hepatitis C virus. N. Engl. J. Med. 368, 1741–1743 (2013).
  CAS PubMed Google Scholar
• Jopling, C. L., Yi, M., Lancaster, A. M., Lemon, S. M. & Sarnow, P. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309, 1577–1581 (2005).
  CAS PubMed Google Scholar
• Obad, S. et al. Silencing of microRNA families by seed-targeting tiny LNAs. Nature Genet. 43, 371–378 (2011).
  CAS PubMed Google Scholar
• Zhang, Y. et al. LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas. Blood 120, 1678–1686 (2012).
  CAS PubMed Google Scholar
• Elmen, J. et al. LNA-mediated microRNA silencing in non-human primates. Nature 452, 896–899 (2008).
  CAS PubMed Google Scholar
• Krutzfeldt, J. et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438, 685–689 (2005).
  PubMed Google Scholar
• Ma, L. et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nature Biotech. 28, 341–347 (2010).
  CAS Google Scholar
• Ebert, M. S., Neilson, J. R. & Sharp, P. A. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nature Methods 4, 721–726 (2007).
  CAS PubMed Google Scholar
• Valastyan, S. et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137, 1032–1046 (2009).
  CAS PubMed PubMed Central Google Scholar
• Ma, L. et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nature Cell Biol. 12, 247–256 (2010).
  CAS PubMed Google Scholar
• Kluiver, J. et al. Rapid generation of microRNA sponges for microRNA inhibition. PLoS ONE 7, e29275 (2012).
  CAS PubMed PubMed Central Google Scholar
• Xie, J. et al. Long-term, efficient inhibition of microRNA function in mice using rAAV vectors. Nature Methods 9, 403–409 (2012).
  CAS PubMed PubMed Central Google Scholar
• Davis, S. et al. Potent inhibition of microRNA in vivo without degradation. Nucleic Acids Res. 37, 70–77 (2009).
  CAS PubMed Google Scholar
• Dvinge, H. et al. The shaping and functional consequences of the microRNA landscape in breast cancer. Nature 497, 378–382 (2013).
  CAS PubMed Google Scholar
• Gumireddy, K. et al. Small-molecule inhibitors of microrna miR-21 function. Angew. Chem. Int. Ed Engl. 47, 7482–7484 (2008).
  CAS PubMed PubMed Central Google Scholar
• Young, D. D., Connelly, C. M., Grohmann, C. & Deiters, A. Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma. J. Am. Chem. Soc. 132, 7976–7981 (2010).
  CAS PubMed Google Scholar
• Zhang, S., Chen, L., Jung, E. J. & Calin, G. A. Targeting microRNAs with small molecules: from dream to reality. Clin. Pharmacol. Ther. 87, 754–758 (2010).
  CAS PubMed Google Scholar
• Lehmann, S. M. et al. An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nature Neurosci. 15, 827–835 (2012).
  CAS PubMed Google Scholar
• O'Brien, S. et al. Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia. J. Clin. Oncol. 25, 1114–1120 (2007).
  CAS PubMed Google Scholar
• Jiang, K. Biotech comes to its 'antisenses' after hard-won drug approval. Nature Med. 19, 252 (2013).
  PubMed Google Scholar
• Ding, L. et al. Combined transfection of Bcl-2 siRNA and miR-15a oligonucleotides enhanced methotrexate-induced apoptosis in Raji cells. Cancer Biol. Med. 10, 16–21 (2013).
  PubMed PubMed Central Google Scholar
• Hu, X. et al. The effect of Bcl-2 siRNA combined with miR-15a oligonucleotides on the growth of Raji cells. Med. Oncol. 30, 430 (2013).
  PubMed Google Scholar
• Pieters, R. et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet 370, 240–250 (2007).
  CAS PubMed Google Scholar
• Kotani, A. et al. miR-128b is a potent glucocorticoid sensitizer in MLL–AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221. Blood 114, 4169–4178 (2009).
  CAS PubMed PubMed Central Google Scholar
• Kotani, A. et al. A novel mutation in the miR-128b gene reduces miRNA processing and leads to glucocorticoid resistance of MLL-AF4 acute lymphocytic leukemia cells. Cell Cycle 9, 1037–1042 (2010).
  CAS PubMed Google Scholar
• Bockhorn, J. et al. MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11. Nature Commun. 4, 1393 (2013).
  Google Scholar
• Kim, S. J. et al. Development of microRNA-145 for therapeutic application in breast cancer. J. Control Release 155, 427–434 (2011).
  CAS PubMed Google Scholar
• Corsten, M. F. et al. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res. 67, 8994–9000 (2007).
  CAS PubMed Google Scholar
• Memczak, S. et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495, 333–338 (2013).
  CAS PubMed Google Scholar
• Katayama, S. et al. Antisense transcription in the mammalian transcriptome. Science 309, 1564–1566 (2005).
  PubMed Google Scholar
• Faghihi, M. A. & Wahlestedt, C. Regulatory roles of natural antisense transcripts. Nature Rev. Mol. Cell Biol. 10, 637–643 (2009).
  CAS Google Scholar
• Calin, G. A. et al. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell 12, 215–229 (2007).
  CAS PubMed Google Scholar
• Orom, U. A. et al. Long noncoding RNAs with enhancer-like function in human cells. Cell 143, 46–58 (2010).
  CAS PubMed PubMed Central Google Scholar
• Gupta, R. A. et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071–1076 (2010).
  CAS PubMed PubMed Central Google Scholar
• Rinn, J. L. et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129, 1311–1323 (2007).
  CAS PubMed PubMed Central Google Scholar
• Wang, K. C. & Chang, H. Y. Molecular mechanisms of long noncoding RNAs. Mol. Cell 43, 904–914 (2011).
  CAS PubMed PubMed Central Google Scholar
• Khalil, A. M. et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc. Natl Acad. Sci. USA 106, 11667–11672 (2009).
  CAS PubMed PubMed Central Google Scholar
• Ji, P. et al. MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22, 8031–8041 (2003).
  PubMed Google Scholar
• Huarte, M. et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142, 409–419 (2010).
  CAS PubMed PubMed Central Google Scholar
• Faghihi, M. A. & Wahlestedt, C. RNA interference is not involved in natural antisense mediated regulation of gene expression in mammals. Genome Biol. 7, R38 (2006).
  PubMed PubMed Central Google Scholar
• Ling, H. et al. CCAT2, a novel non-coding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res. 23, 1446–1461 (2013).
  CAS PubMed PubMed Central Google Scholar
• Salmena, L., Poliseno, L., Tay, Y., Kats, L. & Pandolfi, P. P. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146, 353–358 (2011).
  CAS PubMed PubMed Central Google Scholar
• Poliseno, L. et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465, 1033–1038 (2010).
  CAS PubMed PubMed Central Google Scholar
• Hung, T. et al. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nature Genet. 43, 621–629 (2011).
  CAS PubMed Google Scholar
• Wheeler, T. M. et al. Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature 488, 111–115 (2012).
  CAS PubMed PubMed Central Google Scholar
• Li, C. H. & Chen, Y. Targeting long non-coding RNAs in cancers: progress and prospects. Int. J. Biochem. Cell Biol. 45, 1895–1910 (2013).
  CAS PubMed Google Scholar
• Gutschner, T. et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 73, 1180–1189 (2013).
  CAS PubMed Google Scholar
• Kino, T., Hurt, D. E., Ichijo, T., Nader, N. & Chrousos, G. P. Noncoding RNA Gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci. Signal. 3, ra8 (2010).
  PubMed PubMed Central Google Scholar
• Rusk, N. AntagoNATs boost gene expression. Nature Methods 9, 437 (2012).
  CAS PubMed Google Scholar
• Modarresi, F. et al. Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation. Nature Biotech. 30, 453–459 (2012).
  CAS Google Scholar
• Kim, D. H. & Rossi, J. J. Strategies for silencing human disease using RNA interference. Nature Rev. Genet. 8, 173–184 (2007).
  CAS PubMed Google Scholar
• Pecot, C. V., Calin, G. A., Coleman, R. L., Lopez-Berestein, G. & Sood, A. K. RNA interference in the clinic: challenges and future directions. Nature Rev. Cancer 11, 59–67 (2011).
  CAS Google Scholar
• Whitehead, K. A., Langer, R. & Anderson, D. G. Knocking down barriers: advances in siRNA delivery. Nature Rev. Drug Discov. 8, 129–138 (2009).
  CAS Google Scholar
• Broderick, J. A. & Zamore, P. D. MicroRNA therapeutics. Gene Ther. 18, 1104–1110 (2011).
  CAS PubMed PubMed Central Google Scholar
• Pai, S. I. et al. Prospects of RNA interference therapy for cancer. Gene Ther. 13, 464–477 (2006).
  CAS PubMed Google Scholar
• Flemming, A. Regulatory watch: pioneering gene therapy on brink of approval. Nature Rev. Drug Discov. 11, 664 (2012).
  CAS Google Scholar
• Gruber, K. Europe gives gene therapy the green light. Lancet 380, e10 (2012).
  PubMed Google Scholar
• de Pontual, L. et al. Germline deletion of the miR-17 approximately 92 cluster causes skeletal and growth defects in humans. Nature Genet. 43, 1026–1030 (2011).
  CAS PubMed Google Scholar
• Okamura, K. & Lai, E. C. Endogenous small interfering RNAs in animals. Nature Rev. Mol. Cell Biol. 9, 673–678 (2008).
  CAS Google Scholar
• Kim, V. N. Small RNAs just got bigger: Piwi-interacting RNAs (piRNAs) in mammalian testes. Genes Dev. 20, 1993–1997 (2006).
  CAS PubMed Google Scholar
• Kiss, T. Small nucleolar RNAs: an abundant group of noncoding RNAs with diverse cellular functions. Cell 109, 145–148 (2002).
  CAS PubMed Google Scholar
• Taft, R. J. et al. Small RNAs derived from snoRNAs. RNA 15, 1233–1240 (2009).
  CAS PubMed PubMed Central Google Scholar
• Taft, R. J. et al. Tiny RNAs associated with transcription start sites in animals. Nature Genet. 41, 572–578 (2009).
  CAS PubMed Google Scholar
• Langenberger, D. et al. Evidence for human microRNA-offset RNAs in small RNA sequencing data. Bioinformatics 25, 2298–2301 (2009).
  CAS PubMed Google Scholar
• Wang, X. J., Gaasterland, T. & Chua, N. H. Genome-wide prediction and identification of _cis_-natural antisense transcripts in Arabidopsis thaliana. Genome Biol. 6, R30 (2005).
  PubMed PubMed Central Google Scholar
• Hansen, T. B. et al. Natural RNA circles function as efficient microRNA sponges. Nature 495, 384–388 (2013).
  CAS PubMed Google Scholar
• Guttman, M. et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458, 223–227 (2009).
  CAS PubMed PubMed Central Google Scholar
• Lai, F. et al. Activating RNAs associate with Mediator to enhance chromatin architecture and transcription. Nature 494, 497–501 (2013).
  CAS PubMed PubMed Central Google Scholar
• Hwang, H. W., Wentzel, E. A. & Mendell, J. T. A hexanucleotide element directs microRNA nuclear import. Science 315, 97–100 (2007).
  CAS PubMed Google Scholar
• Forman, J. J., Legesse-Miller, A. & Coller, H. A. A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc. Natl Acad. Sci. USA 105, 14879–14884 (2008).
  CAS PubMed PubMed Central Google Scholar
• Place, R. F., Li, L. C., Pookot, D., Noonan, E. J. & Dahiya, R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc. Natl Acad. Sci. USA 105, 1608–1613 (2008).
  CAS PubMed PubMed Central Google Scholar
• Redis, R. S., Calin, S., Yang, Y., You, M. J. & Calin, G. A. Cell-to-cell miRNA transfer: from body homeostasis to therapy. Pharmacol. Ther. 136, 169–174 (2012).
  CAS PubMed Google Scholar
• Yang, M. et al. Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol. Cancer 10, 117 (2011).
  CAS PubMed PubMed Central Google Scholar
• Liu, Y. et al. Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells. Am. J. Pathol. 176, 2490–2499 (2010).
  CAS PubMed PubMed Central Google Scholar
• Fabbri, M. et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl Acad. Sci. USA 104, 15805–15810 (2007).
  CAS PubMed PubMed Central Google Scholar
• Calin, G. A. et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl Acad. Sci. USA 101, 2999–3004 (2004).
  CAS PubMed PubMed Central Google Scholar
• Klein, U. et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 17, 28–40 (2010).
  CAS PubMed Google Scholar
• Wojcik, S. E. et al. Non-codingRNA sequence variations in human chronic lymphocytic leukemia and colorectal cancer. Carcinogenesis 31, 208–215 (2010).
  CAS PubMed Google Scholar
• Fabbri, M., Valeri, N. & Calin, G. A. MicroRNAs and genomic variations: from Proteus tricks to Prometheus gift. Carcinogenesis 30, 912–917 (2009).
  CAS PubMed Google Scholar
• Fabbri, M. MicroRNAs and cancer epigenetics. Curr. Opin. Investig. Drugs 9, 583–590 (2008).
  CAS PubMed Google Scholar
• Chen, X. et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18, 997–1006 (2008).
  CAS PubMed Google Scholar
• Zhang, H. L. et al. Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy. Prostate 71, 326–331 (2011).
  CAS PubMed Google Scholar
• Cheng, H. et al. Circulating plasma miR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS ONE 6, e17745 (2011).
  CAS PubMed PubMed Central Google Scholar
• Ma, L., Teruya-Feldstein, J. & Weinberg, R. A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449, 682–688 (2007).
  CAS PubMed Google Scholar
• Cimmino, A. et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl Acad. Sci. USA 102, 13944–13949 (2005).
  CAS PubMed PubMed Central Google Scholar
• Dews, M. et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nature Genet. 38, 1060–1065 (2006).
  CAS PubMed Google Scholar
• Mendell, J. T. miRiad roles for the miR-17-92 cluster in development and disease. Cell 133, 217–222 (2008).
  CAS PubMed PubMed Central Google Scholar
• Chan, J. A., Krichevsky, A. M. & Kosik, K. S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 65, 6029–6033 (2005).
  CAS PubMed Google Scholar
• Meng, F. et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133, 647–658 (2007).
  CAS PubMed Google Scholar
• Chang, T. C. et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell 26, 745–752 (2007).
  CAS PubMed PubMed Central Google Scholar
• He, L. et al. A microRNA component of the p53 tumour suppressor network. Nature 447, 1130–1134 (2007).
  CAS PubMed PubMed Central Google Scholar
• Raver-Shapira, N. et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell 26, 731–743 (2007).
  CAS PubMed Google Scholar
• Liu, C. et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nature Med. 17, 211–215 (2011).
  CAS PubMed Google Scholar
• Yang, S. et al. MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1. Oncogene 32, 4294–4303 (2012).
  PubMed Google Scholar
• Eis, P. S. et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl Acad. Sci. USA 102, 3627–3632 (2005).
  CAS PubMed PubMed Central Google Scholar
• Tavazoie, S. F. et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451, 147–152 (2008).
  CAS PubMed PubMed Central Google Scholar
• Huang, Q. et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nature Cell Biol. 10, 202–210 (2008).
  CAS PubMed Google Scholar
• Johnson, S. M. et al. RAS is regulated by the let-7 microRNA family. Cell 120, 635–647 (2005).
  CAS PubMed Google Scholar
• Sampson, V. B. et al. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res. 67, 9762–9770 (2007).
  CAS PubMed Google Scholar
• Tsang, W. P. & Kwok, T. T. Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3. Apoptosis 13, 1215–1222 (2008).
  CAS PubMed Google Scholar
• Zalfa, F. et al. Fragile X mental retardation protein (FMRP) binds specifically to the brain cytoplasmic RNAs BC1/BC200 via a novel RNA-binding motif. J. Biol. Chem. 280, 33403–33410 (2005).
  CAS PubMed Google Scholar
• Muddashetty, R. et al. Poly(A)-binding protein is associated with neuronal BC1 and BC200 ribonucleoprotein particles. J. Mol. Biol. 321, 433–445 (2002).
  CAS PubMed Google Scholar
• Tripathi, V. et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell 39, 925–938 (2010).
  CAS PubMed PubMed Central Google Scholar
• Wilusz, J. E., Freier, S. M. & Spector, D. L. 3′ end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA. Cell 135, 919–932 (2008).
  CAS PubMed PubMed Central Google Scholar
• Crawford, E. D. et al. Diagnostic performance of PCA3 to detect prostate cancer in men with increased prostate specific antigen: a prospective study of 1,962 cases. J. Urol. 188, 1726–1731 (2012).
  PubMed Google Scholar
• Dias, N. & Stein, C. A. Antisense oligonucleotides: basic concepts and mechanisms. Mol. Cancer Ther. 1, 347–355 (2002).
  CAS PubMed Google Scholar
• Novina, C. D. & Sharp, P. A. The RNAi revolution. Nature 430, 161–164 (2004).
  CAS PubMed Google Scholar